期刊文献+

溃疡性结肠炎患者血栓前状态分子标志物的变化及其临床意义 被引量:20

The levels of molecular markers of prethrombotic state in patients with ulcerative colitis and its significance
下载PDF
导出
摘要 目的探讨溃疡性结肠炎(UC)患者凝血、抗凝及纤溶指标的变化与溃疡性结肠炎的活动性及病变范围的关系。方法采用ELISA法检测32例活动期UC患者,20例缓解期UC患者及45例健康对照组的血小板颗粒膜蛋白-140(GMP-140),血管性假性血友病因子(vWF:Ag),血栓调节蛋白(TM),D-二聚体(DD)的含量,采用发色底物法测定抗凝血酶-Ⅲ:活性(AT-Ⅲ:A)并进行分析。结果活动期UC患者GMP-140,vWF:Ag,TM,D-D的含量均明显高于缓解期患者及对照组,缓解期UC患者血栓前状态分子标志物水平明显高于对照组,而AT-Ⅲ:A在活动期UC患者明显低于缓解期患者及对照组。不同病变部位的活动期UC患者血栓前状态标志物水平有明显差异,活动期与缓解期UC患者各指标之间呈显著相关。结论UC患者处于明显的血栓前状态,血栓前状态分子标志物水平与病变活动性及病变范围有关,持续的高凝状态可能与UC患者的临床进展有关。 Objective To explore the changes of markers of coagulation,anticoagulation and fibrinolysis,and relation ship to clinical activity and extent of ulcerative colitis( UC). Methods The plasma levels of granular membrane protein - 140 ( GMP - 140), Yon Willbrand factor antigen ( vWF : Ag), thrombomodulin ( TM ), D - Dimer(DD) in 32 patients with active UC, 20 patients with remissive UC and 45 controls were measured by enzyme linked immunosorbant assays (ELISA). Anti -thrombomodulin Ⅲ activity (AT -Ⅲ:A)was determined by chromogenic substrate method. Results The concentrations of GMP - 140, vWF : Ag, TM, DD were significantly increased in patients with active UC compared with patients with remissive UC and healthy controls. Compared with healthy controls, these indexes in patients with remissive UC also increased significantly. Mean while, the level of AT-Ⅲ : A was significantly decreased in patients with active UC compared with patients with remissive UC and healthy controls. The plasma levels of these indexes were significantly different between different distributions in patients with active UC. There were significant correlations between the molecular markers of prethrombotic state. Conclusion The results suggested that there was an obvious prethrombotic state in patients with UC. The levels of GMP- 140, vWF: Ag,TM, DD ,AT- Ⅲ: A were correlated with activity and severity of UC. Persistent hypercoagulation may contribute to the clinical course of ulcerative colitis.
出处 《胃肠病学和肝病学杂志》 CAS 2007年第2期187-189,共3页 Chinese Journal of Gastroenterology and Hepatology
关键词 溃疡性结肠炎 炎症性肠病 凝血 纤溶 Ulcerative colitis Inflammatory bowel disease Coagulation Fibrinolysis
  • 相关文献

参考文献9

  • 1Fioeehi C. Inflammatory bowel disease : etiology and pathogenesis [ J ]. Gastroenterology, 1998,115 ( 1 ) : 182-205.
  • 2Hayat M, Ariens RA, Moayyedi P, et al. Coagulation factor ⅩⅢ and markers of thrombin generation and fibrinolysis in patients with inflammatory bowel disease [ J ]. Eur J Gastroenterol Hepatol, 2002,14 ( 3 ) : 249 -256.
  • 3Kjeldsen J,Lassen JF,Brandslund I, et al. Markers of coagulation and fibinolysis as measures of disease activity in inflammatory bowel disease [ J]. Scand J Gastroenterol 1998,33(6) :637-643.
  • 4欧阳钦,潘国宗,温忠慧,万学红,胡仁伟,林三仁,胡品津.对炎症性肠病诊断治疗规范的建议[J].中华内科杂志,2001,40(2):138-141. 被引量:550
  • 5Larsen TB, Nielsen JN, Fredholm L, et al. Platelets and anticoagulant capacity in patients with inflammatory bowel disease [ J ]. Pathophysiol Haemost Thromb, 2002,32 ( 2 ) : 92-96.
  • 6Kapsoritakis AN, Koukourakis MI, Sfiridaki A, et al. Mean platelet volume :a useful marker of inflammatory bowel disease activity [ J ]. Am J Gastroenterol,2001,96(3) :776-781.
  • 7Van Bodegraven AA,Schoorl M, Baak JP, et al. Hemostatic imbalance in active and quiescent ulcerative colitis[ J]. Am J Gastroenterol,2001, 96(2) :487-493.
  • 8Fagerstam JP, Whiss PA ,Strom M, et al. Expression of platelet P-selectin and detection of soluble P-selectin, NPY and RANTES in patients with inflammatory bowel disease [ J ]. Inflamm Res,2000,49 (9) :466- 472.
  • 9贺国斌,欧阳钦.溃疡性结肠炎的血栓前状态与肝素治疗[J].国外医学(内科学分册),2000,27(6):238-241. 被引量:37

二级参考文献5

  • 1Berendt W. Aichbichler,Wolfgang Petritsch,Gerhard A. Reicht,Heimo H. Wenzl,Andreas J. Eherer,Thomas A. Hinterleitner,Piet Auer-Grumbach,Guenter J. Krejs.Anti-Cardiolipin Antibodies in Patients with Inflammatory Bowel Disease[J].Digestive Diseases and Sciences.1999(4)
  • 2I. E. Koutroubakis,E. Petinaki,E. Anagnostopoulou,H. Kritikos,I. A. Mouzas,E. A. Kouroumalis,O. N. Manousos.Anti-cardiolipin and Anti-β2-glycoprotein I Antibodies in Patients with Inflammatory Bowel Disease[J].Digestive Diseases and Sciences.1998(11)
  • 3Antoni Stadnicki,Maciej Gonciarz,Tomasz J. Niewiarowski,Jacek Hartleb,Marek Rudnicki,Nancy B. Merrell,Raul A. Dela Cadena,Robert W. Colman.Coagulation Systems and Neutrophils in the Activation of Plasma Contact and Active Phase of Ulcerative Colitis[J].Digestive Diseases and Sciences.1997(11)
  • 4Dr. Joan Carles Souto MD,Elisabet Martínez BSc,Martí Roca PhD,José Mateo MD,Joan Pujol MD,Dolors González MD,Jordi Fontcuberta PhD.Prothrombotic state and signs of endothelial lesion in plasma of patients with inflammatory bowel disease[J].Digestive Diseases and Sciences.1995(9)
  • 5Dr. Maureen G. Conlan MD,William D. Haire MD,David A. Burnett MD.Prothrombotic abnormalities in inflammatory bowel disease[J].Digestive Diseases and Sciences.1989(7)

共引文献575

同被引文献237

引证文献20

二级引证文献117

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部